Evidence map›Paper›PMID 36999411›Full record

ArticleAnti-cancer agents in medicinal chemistry2024

Potsangbam Jolly Devi, Asem Robinson Singh, Naorem Tarundas Singh, Laishram Rupachandra Singh, Sanjenbam Kunjeshwori Devi, Lisam Shanjukumar Singh

Abstract read
PubMed Publisher
In one paragraph

Article in Anti-cancer agents in medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Potsangbam Jolly DeviDepartment of Biochemistry, Laboratory of Protein Biochemistry, Manipur University, Canchipur Imphal, Manipur, 795003, India.
Asem Robinson SinghDepartment of Biotechnology, Cancer and Molecular Biology Division, Manipur University, Canchipur Imphal, Manipur, 795003, India.
Naorem Tarundas SinghDepartment of Biotechnology, Cancer and Molecular Biology Division, Manipur University, Canchipur Imphal, Manipur, 795003, India.
Laishram Rupachandra SinghDepartment of Biochemistry, Laboratory of Protein Biochemistry, Manipur University, Canchipur Imphal, Manipur, 795003, India.
Sanjenbam Kunjeshwori DeviDepartment of Biochemistry, Laboratory of Protein Biochemistry, Manipur University, Canchipur Imphal, Manipur, 795003, India.
Lisam Shanjukumar SinghDepartment of Biotechnology, Cancer and Molecular Biology Division, Manipur University, Canchipur Imphal, Manipur, 795003, India.
Manipur University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn spite of much progress in cancer, the global cancer burden is still significant and increasing. Sericin, an adhesive protein of silk cocoons, has been shown to be a potential protein in various biomedical applications, including cancer therapeutics. The present study evaluates the anticancer property of sericin from cocoons of

objectiveEstablish the antiproliferative potential of SAP. 2. Identify the molecular mechanism of cell death induced by SAP on two different cell lines.

aimsTo investigate the anticancer activity of sericin preparation from cocoons of

methodsSAP was prepared from cocoons of

resultsSAP causes cytotoxicity to A549 and HeLa cell lines with the IC

conclusionThe difference in the molecular mechanisms of apoptosis induced by SAP in A549 and HeLa cell lines may be due to the difference in the genotypes of the cancer cell lines. However, further investigation is warranted. The overall results of the present study envisage the possibility of using SAP as an anti-tumorigenic agent.

Indexed as

Antineoplastic AgentsApoptosisCaspasesCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorSericinsA549 CellsAnimalsCell SurvivalHeLa CellsHumansMolecular StructureMothsStructure-Activity RelationshipAntineoplastic AgentsCaspasesSericinsAntheraea proylei J.Caspase-3MAPK.PARPSericinsilk cocoons

Identifiers

PMID36999411
OpenAlexW4361268307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.